Alicia Villanueva

Statistics

Publications

Citations

H-Index

Active since

2012

Affiliations

Hospital Universitari de Vic(Current)

Victoria University of Wellington

Consorci d’Atenció Primària de Salut Barcelona Esquerra

Universidad de Guadalajara

Instituto Dante Pazzanese de Cardiologia

Alicia Villanueva is an author at Hospital Universitari de Vic specializing in medicine, placebo-controlled efficacy assessment, and end-of-life care.

Publications per year

2012–2019

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Identifying patients with chronic conditions in need of palliative care in the general population: development of the NECPAL tool and preliminary prevalence rates in Catalonia

Xavier Gómez‐Batiste, Marisa Martínez-Muñoz, Carles Blay et al. · BMJ Supportive & Palliative Care · 2012 · 190 citations

Medicine, Oncology, End-of-life Care +9

Utility of the NECPAL CCOMS-ICO <sup>©</sup> tool and the Surprise Question as screening tools for early palliative care and to predict mortality in patients with advanced chronic conditions: A cohort study

Xavier Gómez‐Batiste, Marisa Martínez-Muñoz, Carles Blay et al. · Palliative Medicine · 2016 · 154 citations

Medicine, Internal Medicine, End-of-life Care +15

1–4 of 4